Amifostine

FDA Approved: * March 14, 2008
Pharm Company: * SUN PHARM INDS LTD
Category: Cancer

Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. Contents 1 Indications 2 Pharmacokinetics 3 Mechanism of action 4 Adverse effects 5 Contraindications 6 References Indications Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Amifostine 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 47335-581

Labeler:

Sun Pharma Global Fze

Amifostine 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 55390-308

Labeler:

Bedford Laboratories

Amifostine 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 62756-581

Labeler:

Sun Pharmaceutical Industries Limited

Related Brands

Drugs with the same active ingredients

Ethyol

Popular Topics

Amifostine suppository

radiaation therapy ## Manufacturing formula of Amifostine suppository & one of the article of this topic. ## Amifost...

2 REPLIES

Subcutaneous Amifostine

The article on amifostine says it can ONLY be administered intravenously but this is NOT TRUE. Subcutaneous injection of...

Manufacturing formula of Amifostine Suppository

Amifostine 500 mg Suppository...